| Effect of dutasteride on the risk of prostate cancer GL Andriole, DG Bostwick, OW Brawley, LG Gomella, M Marberger, ... New England Journal of Medicine 362 (13), 1192-1202, 2010 | 1350 | 2010 |
| Micro-RNA profiling in kidney and bladder cancers F Gottardo, CG Liu, M Ferracin, GA Calin, M Fassan, P Bassi, C Sevignani, ... Urologic Oncology: Seminars and Original Investigations 25 (5), 387-392, 2007 | 786 | 2007 |
| MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets R Baffa, M Fassan, S Volinia, B O'Hara, CG Liu, JP Palazzo, M Gardiman, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 622 | 2009 |
| Analysis of 13 cell types reveals evidence for the expression of numerous novel primate-and tissue-specific microRNAs E Londin, P Loher, AG Telonis, K Quann, P Clark, Y Jing, E Hatzimichael, ... Proceedings of the National Academy of Sciences 112 (10), E1106-E1115, 2015 | 513 | 2015 |
| Detection of hematogenous micrometastasis in patients with prostate cancer JG Moreno, CM Croce, R Rischer, M Monne, P Vihko, SG Mulholland, ... Cancer Research 52 (21), 6110-6112, 1992 | 492 | 1992 |
| Dual roles of PARP-1 promote cancer growth and progression MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ... Cancer discovery 2 (12), 1134-1149, 2012 | 460 | 2012 |
| Utilization of polymerase chain reaction technology in the detection of solid tumors GV Raj, JG Moreno, LG Gomella Cancer: Interdisciplinary International Journal of the American Cancer …, 1998 | 358 | 1998 |
| Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial G Andriole, D Bostwick, O Brawley, L Gomella, M Marberger, D Tindall, ... The Journal of urology 172 (4 Part 1), 1314-1317, 2004 | 356 | 2004 |
| The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression A Sharma, WS Yeow, A Ertel, I Coleman, N Clegg, C Thangavel, ... The Journal of clinical investigation 120 (12), 4478-4492, 2010 | 353 | 2010 |
| A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III … Y Fradet, HB Grossman, L Gomella, S Lerner, M Cookson, D Albala, ... The Journal of urology 178 (1), 68-73, 2007 | 348 | 2007 |
| A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with … HB Grossman, L Gomella, Y Fradet, A Morales, J Presti, C Ritenour, ... The Journal of urology 178 (1), 62-67, 2007 | 342 | 2007 |
| Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. GR Hudes, F Nathan, C Khater, N Haas, M Cornfield, B Giantonio, ... Journal of clinical oncology 15 (9), 3156-3163, 1997 | 341 | 1997 |
| Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor Z Pietrzkowski, G Mulholland, L Gomella, BA Jameson, D Wernicke, ... Cancer Research 53 (5), 1102-1106, 1993 | 324 | 1993 |
| Circulating tumor cells predict survival in patients with metastatic prostate cancer JG Moreno, MC Miller, S Gross, WJ Allard, LG Gomella, ... Urology 65 (4), 713-718, 2005 | 288 | 2005 |
| Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing MA Bjurlin, HB Carter, P Schellhammer, MS Cookson, LG Gomella, ... The Journal of urology 189 (6), 2039-2046, 2013 | 262 | 2013 |
| Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial SA Boorjian, M Alemozaffar, BR Konety, ND Shore, LG Gomella, ... The lancet oncology 22 (1), 107-117, 2021 | 259 | 2021 |
| Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. EK Outwater, RO Petersen, ES Siegelman, LG Gomella, CE Chernesky, ... Radiology 193 (2), 333-339, 1994 | 239 | 1994 |
| Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy RB Den, K Yousefi, EJ Trabulsi, F Abdollah, V Choeurng, FY Feng, ... Journal of Clinical Oncology 33 (8), 944, 2015 | 230 | 2015 |
| Implementation of germline testing for prostate cancer: Philadelphia Prostate Cancer Consensus Conference 2019 VN Giri, KE Knudsen, WK Kelly, HH Cheng, KA Cooney, MS Cookson, ... Journal of Clinical Oncology 38 (24), 2798, 2020 | 226 | 2020 |
| Retroperitoneal and pelvic extraperitoneal laparoscopy: an international perspective IS Gill, RV Clayman, DM Albala, Y Aso, AW Chiu, S Das, JF Donovan, ... Urology 52 (4), 566-571, 1998 | 225 | 1998 |
Adam DickerThomas Jefferson UniversityBestätigte E-Mail-Adresse bei jefferson.edu
